The future of bioengineering in cancer looks promising, with ongoing advancements in artificial intelligence, machine learning, and nanotechnology. These technologies have the potential to further enhance diagnostic accuracy, treatment efficacy, and personalization of cancer therapies. Continued interdisciplinary collaboration between engineers, biologists, and clinicians will be key to overcoming current challenges and making significant strides in the fight against cancer.
